Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Feldbach – page 6

134 clinical trials in Feldbach, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Feldbach at a glance
134
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

134 trials in Feldbach

Open in trial search

Septic shock

Not yet recruiting

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Chronic lymphocytic leukaemia+1

Not yet recruiting

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nemtabrutinib
  • Sponsor:French Innovative Leukemia Organization

T-cell type acute leukaemia

Not yet recruiting

Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Asparaginase
  • Sponsor:Centre Hospitalier De Versailles

Infertility male

Not yet recruiting

Study evaluating the effect of isotretinoin on sperm production in men with low sperm count

Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Isotretinoin
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Cardiac failure+1

Not yet recruiting

A feasibility study of dapagliflozin for elderly patients hospitalized with chronic heart failure.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Dapagliflozin Propanediol Monohydrate
  • Sponsor:Centre Hospitalier Regional Universitaire

Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:French Innovative Leukemia Organization

Non-small cell lung cancer

Not yet recruiting

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Taiho Oncology Inc.

Chronic kidney disease+3

Not yet recruiting

Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Vienna

Plasma cell myeloma

Not yet recruiting

Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Carfilzomib
  • Sponsor:Intergroupe Francophone Du Myelome

Pneumonia

Not yet recruiting

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cholesterol
  • Sponsor:Eagle Pharmaceuticals Inc.

Sjogren's syndrome

Not recruiting

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Feldbach

What the registry says about research in the country

01 Respiratory Medicine

Groundbreaking research focusing on severe asthma and its treatment through innovative therapies. Studies are evaluating new approaches for patients with eosinophilic phenotype who have previously responded to specific treatments.

  • Severe asthma management
  • Eosinophilic inflammation
  • Treatment comparison studies

These trials aim to improve long-term outcomes for patients with severe respiratory conditions.

02 COPD Research

Comprehensive studies examining chronic obstructive pulmonary disease treatments, including evaluation of triple therapy combinations and novel therapeutic approaches.

  • Exacerbation reduction
  • Triple therapy effectiveness
  • Bronchodilator combinations

Research focuses on improving quality of life and reducing severe cardiopulmonary outcomes.

03 Nephrology Studies

Important research investigating treatments for patients with chronic kidney disease and those requiring hemodialysis, with a focus on cardiovascular outcomes.

  • Kidney failure management
  • Cardiovascular complications
  • Hemodialysis optimization

These trials aim to enhance treatment options for patients with complex kidney conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.